LIFE - Company ID 0001339970
aTYR PHARMA INC (LIFE) reported net income of -$74.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$74.12M | -15.8% |
| FY 2024 | -$64.02M | -27.1% |
| FY 2023 | -$50.39M | -11.1% |
| FY 2022 | -$45.34M | -34.3% |
| FY 2021 | -$33.77M | -108.1% |
| FY 2020 | -$16.22M | +0.0% |
| FY 2019 | -$16.22M | +53.0% |
| FY 2018 | -$34.52M | +28.4% |
| FY 2017 |
aTYR PHARMA INC (LIFE) reported net income of -$74.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, aTYR PHARMA INC's net income declined from -$20.01M to -$74.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$48.21M |
| +16.7% |
| FY 2016 | -$57.85M | -20.6% |
| FY 2015 | -$47.97M | -97.0% |
| FY 2014 | -$24.35M | -21.7% |
| FY 2013 | -$20.01M | - |